Cardinal Health (CAH) stock has attracted fresh attention after recent performance data highlighted mixed returns, with gains over the past year but a decline over the past 3 months, prompting investors to reassess its current valuation.

At a share price of $200.68, Cardinal Health’s recent share price return has been soft over the past 3 months, even though the 1 year total shareholder return of 32.86% and 5 year total shareholder return of 301.64% point to momentum that has built over a longer period.

If you are comparing Cardinal Health with other opportunities in healthcare and beyond, this is a good moment to broaden your search using our screener of 34 healthcare AI stocks.

With the stock at $200.68 after a softer recent stretch but strong multi year total returns and solid reported revenue and net income growth, is Cardinal Health still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 18.2% Undervalued

Based on the most followed narrative, Cardinal Health's fair value of $245.27 sits well above the last close at $200.68, which frames the recent pullback in a very different light.

The strong performance and continued investment in Other growth businesses such as at-Home Solutions, Nuclear and Precision Health, and OptiFreight Logistics aligns with the growing trend of outpatient and home healthcare, underpinning diversified revenue growth and supporting margin expansion.

Curious what kind of revenue mix, margin lift, and earnings profile has to materialize for that valuation to stack up? The narrative leans heavily on steady top line expansion, modest margin improvement, and a richer future earnings multiple to bridge the gap.

Result: Fair Value of $245.27 (UNDERVALUED)

However, this upbeat narrative can be knocked off course if tighter regulation or pricing scrutiny compresses margins, or if key customer contracts expire faster than expected.

Another View: What The P/E Is Telling You

While the SWS DCF model points to Cardinal Health trading well below an estimated fair value, the current P/E of 30.2x tells a different story. It sits above both the US Healthcare sector at 24.6x and the peer average at 23.6x, and also above a fair ratio of 27.3x, which means a lot of optimism is already in the price. That kind of premium can reward patience if the growth story stays intact, but it can also magnify disappointment if earnings or margins fall short. Which side of that trade are you most comfortable with?

Next Steps

With mixed signals on valuation and sentiment, this is an important time to review the charts and fundamentals yourself and decide how comfortable you are with both the upside and the downside reflected in 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Cardinal Health has you thinking more broadly about your portfolio, this is the moment to cast a wider net and see what else deserves attention.

• Spot potential mispricings early by scanning a curated set of 48 high quality undervalued stocks that pair quality fundamentals with attractive valuations.
• Strengthen your income stream by reviewing companies in the 10 dividend fortresses that offer higher yields with a focus on durability.
• Protect the downside first by filtering for 69 resilient stocks with low risk scores that aim to balance resilience with sensible return potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.